PhenoAge is not a wellness score. It's not a self-assessment questionnaire. It's a mortality risk model — built from 9 blood biomarkers, validated against a nationally representative dataset of over 11,000 people, and published in the Proceedings of the National Academy of Sciences in 2018.
It is, in my view, one of the most practically useful clinical tools to emerge from the longevity research space in recent years. And it's widely misunderstood — so I want to explain exactly what it is and why it matters.
PhenoAge was developed by Morgan Levine and colleagues at Yale, using data from the US National Health and Nutrition Examination Survey (NHANES). The researchers were looking for a way to capture biological ageing using markers that are routinely available from a standard blood panel — not expensive research assays, not epigenetic testing, not novel biomarkers.
Their approach was to identify the combination of biomarkers that best predicted mortality risk — and then construct an "age" from that combination. The result is a number that represents the age of someone in the general population with that same risk profile.
If your PhenoAge is lower than your chronological age, your biology resembles someone younger — with lower predicted risk. If it's higher, the reverse is true.
What makes PhenoAge practical is that it uses markers already present in a standard blood panel:
Each of these individually tells you something. Together, weighted and combined the way Levine's model specifies, they give you a biological age estimate that has been shown to outperform chronological age in predicting mortality, chronic disease incidence, and physical functioning.
A PhenoAge result that's 5 years younger than your chronological age is a meaningful signal. It suggests your biology is performing better than average for your age group, and your mortality risk profile corresponds to someone younger.
A result that's 5 years older is also a signal — not a diagnosis, not a prognosis, but a prompt. Something in that panel is running high. And because the contributing markers are specific, it points toward where to look: inflammation, metabolic health, immune function, kidney or liver status.
That's what makes it actionable in a way that most health scores aren't. It's not abstract. It connects directly to modifiable biology.
As a single measurement, PhenoAge is informative. As a tracked metric — calculated every 6 to 12 months as you make lifestyle and clinical interventions — it becomes something more useful: a feedback loop.
You change something. You measure again. You see whether the biology moved. That's the approach I use with clients, and it's the only way to know whether what you're doing is actually working at the level of biological age.
If you have a recent blood panel, you can calculate your PhenoAge now.
Open the Calculator →